NCT02047513 2023-06-15
NEONAX
AIO-Studien-gGmbH
Phase 2 Completed
Clinical Trials
3 trialsNCT05679050 2023-01-10
Phase II Study on Sequential AG and FOLFIRINOX as Neoadjuvant Therapy in Patients With Resectable Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Unknown
NCT03392571 2019-05-07
Phase II Study of NGC-Triple Regimen in Potentially Resectable Pancreatic Cancer Patients
Pancreatic Cancer Research Team
Phase 2 Withdrawn